Literature DB >> 26306126

Percutaneous Left Atrial Appendage Ligation for Stroke Prevention in Atrial Fibrillation.

Miguel Valderrábano1, Matthew J Price2.   

Abstract

Prevention of thromboembolic complications in atrial fibrillation remains a tremendous clinical challenge. Knowledge that the left atrial appendage (LAA) is the most common anatomical origin of cardioembolic strokes1 has been the main motivation to develop clinical and procedural strategies to exclude the LAA from the circulation, either surgically or percutaneously. This review discusses the rationale behind these strategies, their relative merits, and future prospects for LAA exclusion strategies.

Entities:  

Keywords:  anticoagulants; atrial fibrillation; left atrial appendage; stroke

Mesh：

Year:  2015        PMID： 26306126      PMCID： PMC4547684          DOI： 10.14797/mdcj-11-2-94

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN： 1947-6108


  49 in total

1.  Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiograhic study.

Authors:  E S Katz; T Tsiamtsiouris; R M Applebaum; A Schwartzbard; P A Tunick; I Kronzon
Journal:  J Am Coll Cardiol       Date:  2000-08       Impact factor: 24.094

2.  Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography.

Authors:  Anne S Kanderian; A Marc Gillinov; Gosta B Pettersson; Eugene Blackstone; Allan L Klein
Journal:  J Am Coll Cardiol       Date:  2008-09-09       Impact factor: 24.094

3.  Exclusion of the left atrial appendage with a novel device: early results of a multicenter trial.

Authors:  Gorav Ailawadi; Marc W Gerdisch; Richard L Harvey; Robert L Hooker; Ralph J Damiano; Thomas Salamon; Michael J Mack
Journal:  J Thorac Cardiovasc Surg       Date:  2011-09-08       Impact factor: 5.209

4.  Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.

Authors:  Vivek Y Reddy; David Holmes; Shephal K Doshi; Petr Neuzil; Saibal Kar
Journal:  Circulation       Date:  2011-01-17       Impact factor: 29.690

5.  Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.

Authors:  David R Holmes; Saibal Kar; Matthew J Price; Brian Whisenant; Horst Sievert; Shephal K Doshi; Kenneth Huber; Vivek Y Reddy
Journal:  J Am Coll Cardiol       Date:  2014-07-08       Impact factor: 24.094

Review 6.  Should patients undergoing cardiac surgery with atrial fibrillation have left atrial appendage exclusion?

Authors:  Alan G Dawson; Sanjay Asopa; Joel Dunning
Journal:  Interact Cardiovasc Thorac Surg       Date:  2009-11-26

7.  Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study.

Authors:  Peter C Block; Steven Burstein; Paul N Casale; Paul H Kramer; Paul Teirstein; David O Williams; Mark Reisman
Journal:  JACC Cardiovasc Interv       Date:  2009-07       Impact factor: 11.195

8.  Rationale and design of the Left Atrial Appendage Occlusion Study (LAAOS) III.

Authors:  Richard Whitlock; Jeff Healey; Jessica Vincent; Kate Brady; Kevin Teoh; Alistair Royse; Pallav Shah; Yingqiang Guo; Marco Alings; Richard J Folkeringa; Domenico Paparella; Andrea Colli; Steven R Meyer; Jean-François Legare; François Lamontagne; Wilko Reents; Andreas Böning; Stuart Connolly
Journal:  Ann Cardiothorac Surg       Date:  2014-01

9.  Quality of life assessment in the randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) trial of patients at risk for stroke with nonvalvular atrial fibrillation.

Authors:  Oluseun Alli; Shepal Doshi; Saibal Kar; Vivek Reddy; Horst Sievert; Chris Mullin; Vijay Swarup; Brian Whisenant; David Holmes
Journal:  J Am Coll Cardiol       Date:  2013-02-28       Impact factor: 24.094

10.  Edoxaban versus warfarin in patients with atrial fibrillation.

Authors:  Robert P Giugliano; Christian T Ruff; Eugene Braunwald; Sabina A Murphy; Stephen D Wiviott; Jonathan L Halperin; Albert L Waldo; Michael D Ezekowitz; Jeffrey I Weitz; Jindřich Špinar; Witold Ruzyllo; Mikhail Ruda; Yukihiro Koretsune; Joshua Betcher; Minggao Shi; Laura T Grip; Shirali P Patel; Indravadan Patel; James J Hanyok; Michele Mercuri; Elliott M Antman
Journal:  N Engl J Med       Date:  2013-11-19       Impact factor: 91.245
View more
  1 in total

Review 1.  Approaches to Left Atrial Appendage Closure: Device Design, Performance, and Limitations.

Authors:  Amish S Dave; Miguel Valderrábano
Journal:  Methodist Debakey Cardiovasc J       Date:  2017 Jul-Sep
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.